Cargando…
Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model
Cases of Middle East respiratory syndrome coronavirus (MERS-CoV) continue to occur, making it one of the WHO´s targets for accelerated vaccine development. One vaccine candidate is based on live-attenuated measles virus (MV) vaccine encoding the MERS-CoV spike glycoprotein (MERS-S). MV(vac2)-MERS-S(...
Autores principales: | Bodmer, Bianca S., Fiedler, Anna H., Hanauer, Jan R.H., Prüfer, Steffen, Mühlebach, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118890/ https://www.ncbi.nlm.nih.gov/pubmed/29902727 http://dx.doi.org/10.1016/j.virol.2018.05.028 |
Ejemplares similares
-
Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors
por: Hanauer, Jan RH, et al.
Publicado: (2016) -
A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9
por: Hörner, Cindy, et al.
Publicado: (2023) -
Vaccine platform recombinant measles virus
por: Mühlebach, Michael D.
Publicado: (2017) -
Development of Recombinant Measles Virus-Based Vaccines
por: Mühlebach, Michael D., et al.
Publicado: (2016) -
Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective
por: Kleinlützum, Dina, et al.
Publicado: (2017)